SAFETY PROFILE OF RUXOLITINIB IN PRIMARY MYELOFIBROSIS, POST-POLYCITEMIA VERA MYELOFIBROSIS AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN A COMPASSIONATE USE PROGRAM (CUP) IN MEXICO
HAEMATOLOGICA(2013)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined